Skip to main content
Search hero banner

Search results

Showing 61 - 80 of 118 results

High Performance Macromolecular Crystallography Beamline (MX3)

High Performance Macromolecular Crystallography Beamline (MX3)

The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.

business-services-irradiation-silicon-ingots-web

Silicon irradiation

ANSTO is one of the world's leading providers of irradiation services for silicon ingots, which are used by the multimillion dollar electronics industry across Europe and Asia. Each year, ANSTO irradiates more than 50 tonnes of silicon.

Health products customer update archive

Archive

See details of previously published customer updates from our Health products team. 

ANSTO supports investigations into new area of COVID research

ANSTO’s National Deuteration Facility has been providing high-quality deuterated lipids used in the construction of cell membrane models to support research that improves our understanding of how the virus interacts with elements of the cell membrane, a relatively new area of investigation.

Helium polariser

Helium 3 Polariser

This state-of-the-art metastable-exchange optical-pumping helium-3 polarising system enables polarisation-analysis experiments on five of our existing instruments.

3D cell printing technology earns ANSTO Eureka Prize for Technology

Researchers and industry partners from UNSW Australia, the Australian Centre for Nanomedicine, Children’s Cancer Institute and Inventia Life Sciences Pty Ltd have been awarded the 2021 ANSTO Eureka Prize for Innovative Use of Technology for their method to rapidly-produce 3D cell structures

Dr Mark Reid
Instrument Scientist

Dr Mark Reid is co-responsible for the

Dr David Boardman
Chief Technology Officer & Principal Scientist, Detection & Imaging

Dr David Boardman is the Chief Technology Officer & Principal Scientist for Detection & Imaging.

Aerial image of ANSTO's Lucas Heights facility

Statement of Intent

In January 2026, Mr Michael Quigley AM, ANSTO Board Chair, shared ANSTO's Statement of Intent with the Minister for Industry and Innovation, and Minister for Science.

After your experiment clayton

After your experiment

Following your experiment at the Australian Synchrotron there are certain tasks that users can complete including a user feedback survey and claiming reimbursement for travel expenses.

Pagination